Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evoke Pharma Inc (NASDAQ:EVOK)

1.54
Delayed Data
As of Dec 09
 0.00 / 0.00%
Today’s Change
1.35
Today|||52-Week Range
11.11
-53.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$19.0M

Company Description

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops EVK-001 for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in Solana Beach, CA.

Contact Information

Evoke Pharma, Inc.
505 Lomas Santa Fe Drive
Solana Beach California 92075
P:(858) 345-1494
Investor Relations:

Employees

Shareholders

Other institutional7.82%
Individual stakeholders21.66%
Mutual fund holders2.54%

Top Executives

David A. GonyerPresident, CEO & Class I Director
Matthew J. D'OnofrioSecretary, Treasurer & Chief Business Officer
Marilyn R. CarlsonChief Medical Officer